Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...